Intimo Medical
Novel Intrauterine Device
Startup Seed Health Tech & Life Sciences Est. 2022
Total Raised
$3.15M
Seed
Last Round
Undisclosed
3 rounds
Investors
3
2 public
Team
2
1-10 employees
Confidence
90/100
News
1
articles
About
Intimo is developing advanced gynecology innovations and strives to provide women with improved safety, comfort, and protection. Its versatile Intrauterine 3-Dimensional Device (IU3D) can provide hormone-free contraception and will eventually target additional clinical indications. Intimo's hormone-free IU3D self-expands into a pear-shaped anatomical structure, adapting to the uterine cavity. Its design reduces the risk of uteruine injury and allows for safe and comfortable use.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Core Technology
Materials & Substances
Target Customer
ConsumersDemographics & FamilyWomenHealthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
femtechgynecologywomenmedical-devicestreatmentswomen-healthdrug-delivery
Funding & Events
May 2025
Seed Undisclosed
NGT HealthCare II, Israel Innovation Authority
May 2025
Non-equity $1.65M
Israel Innovation Authority
Dec 2022
Pre-Seed $1.5M
NGT HealthCare II (Lead), Israel Innovation Authority
News (1)
Dec 10, 2024 · www.digitech.news
growth-positive
Open Accelerator 2024, 5 startups at the center of the Demo Day
InvestmentPartners
Details
Product Stage
R&D
Employees
1-10
Exact Count
3
District
North District
Founded
2022
Registrar
516714847
Locations
Nazareth, Israel
Links
Website
LinkedIn
Admin
Last Update
Oct 23, 2025
Verified by
Yotam Maman
Claimed
Yes
Missing
markets, not claimed
Team (2)
Lior Erez
Co-founder & CEO
Founder
Matan Shabat
Co-founder & Director
Founder
Internal
Created by
Yotam Maman (yotamm1988@gmail.com)
Created
2022-03-23T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)